-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO)
-
-
-
-
-
-
-
Cantor Fitzgerald Starts CervoMed (CRVO) at Overweight
-
-
-
-
-
-
-
CervoMed names Matthew Winton as chief commercial and business officer
-
-
-
-
-
-
-
Chardan Capital Markets Upgrades CervoMed (CRVO) to Buy
-
-
-
-
-
-
-
Brookline Capital Markets Downgrades CervoMed (CRVO) to Hold citing RewinD-LB Topline Data Failure
-
-
-
-
-
-
-
CervoMed (CRVO) Misses Q3 EPS by 55c
-
-
-
-
-
-
-
Brookline Capital Markets Starts CervoMed (CRVO) at Buy
-
474,160 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


